Sara Samari

Sara Samari, PhD, is a Translational Medicine Scientist and Clinical Biomarker Development Lead at ADC Therapeutics since February 2021, focusing on Translational Medicine and Companion Diagnostic strategies. Previously, Sara served as a Bioanalytical Outsourcing Specialist and Postdoctoral Research Associate at Imperial College London, contributing to research on macrophages and their interactions with cardiac progenitor stem cells. Additional experience includes Biobank Tissue Scientist at the NHS, Research Assistant in Neuroscience at SISSA, and an MSc internship in Microbiology at Imperial College London. Educational achievements include a PhD in Cardiovascular Regenerative Medicine and an MRes in Biomedical Research from Imperial College London, along with advanced degrees in Functional Genomics and Cellular and Molecular Technologies.